Gluten is a composite of storage proteins—predominantly gliadin (monomeric) and glutenin (polymeric)—found in wheat, barley, and rye, characterised by unusually high proline and glutamine content. This unique amino acid composition renders gluten highly resistant to complete proteolytic degradation by human gastric and pancreatic enzymes, resulting in bioactive peptide fragments that trigger zonulin-mediated increases in intestinal permeability and, in genetically susceptible individuals (HLA-DQ2/DQ8), an adaptive immune cascade culminating in coeliac disease.
Imagine gluten proteins as reinforced cargo containers entering a recycling plant (your digestive system). Unlike normal containers (other proteins) that easily break down into raw materials, these containers have special locks (proline-glutamine sequences) that jam the cutting machines (proteases). The plant workers struggle, leaving behind a particularly stubborn 33-compartment piece (the 33-mer gliadin peptide) that won't fit through the normal processing channels.
This resistant fragment acts like a skeleton key that accidentally fits the "emergency exit" lock (CXCR3 receptor) on the walls of the plant. When the key turns, it releases a foreman signal (zonulin) that commands all the workers to step back from their posts along the wall. Now the normally tight-fitting wall panels (tight junctions) have gaps between them, and all sorts of unprocessed material starts leaking through into areas it shouldn't reach.
In some people carrying specific genetic blueprints (HLA-DQ2/DQ8), a specialist quality-control officer (tissue transglutaminase) modifies these escaped fragments, stamping them with a "foreign threat" marker. This triggers the security team (T cells) to launch a full-scale defensive response—not just against the container fragments, but against the very machinery (intestinal villi) that let them through, creating permanent structural damage to the plant itself.
Digestion Resistance:
Gluten proteins contain 15-35% proline residues, which create rigid, kinked structures that fit poorly into the active sites of gastric pepsin, pancreatic trypsin, and chymotrypsin. The enzymes DPP IV (dipeptidyl peptidase IV) in the brush border can partially cleave proline-containing bonds, but the 33-amino acid α2-gliadin fragment (positions 57-89) remains completely intact due to nine proline residues in this sequence. This peptide survives the entire gastrointestinal tract without complete degradation.
Zonulin Pathway (Universal Response):
graph TD
A[33-mer gliadin peptide] --> B[Binds CXCR3 receptor on enterocytes]
B --> C[Activates MyD88 signaling]
C --> D[Zonulin release from intestinal epithelium]
D --> E[Zonulin binds PAR-2 and EGFR]
E --> F[PKC pathway activation]
F --> G[Phosphorylation of ZO-1 protein]
G --> H[Disassembly of tight junction complexes]
H --> I[Increased paracellular permeability]
I --> J[LPS and food antigens cross epithelium]
J --> K[Systemic inflammation via TLR4 activation]
The gliadin peptide specifically activates CXCR3 on the apical surface of enterocytes → intracellular MyD88-dependent signaling → zonulin (pre-haptoglobin-2) secretion from both enterocytes and subepithelial cells → zonulin binds protease-activated receptor 2 (PAR-2) and epidermal growth factor receptor (EGFR) → protein kinase C (PKC) activation → phosphorylation of zonula occludens-1 (ZO-1) and occludin → reorganization of F-actin cytoskeleton → reversible opening of tight junctions for 30-90 minutes post-exposure.
Coeliac Disease Pathway (HLA-DQ2/DQ8 Individuals):
graph TD
A[Gliadin peptides cross damaged epithelium] --> B[Encounter tissue transglutaminase tTG in lamina propria]
B --> C["tTG deamidates glutamine → glutamic acid"]
C --> D[Modified peptides bind HLA-DQ2/DQ8 on APCs]
D --> E["CD4+ T cell recognition and activation"]
E --> F["Th1 response: IFN-γ production"]
E --> G["Th2 response: B cell activation"]
F --> H[Cytotoxic T cell activation]
G --> I[Anti-gliadin and anti-tTG antibodies]
H --> J[Enterocyte apoptosis]
I --> K[Immune complex formation]
J --> L[Villous atrophy and crypt hyperplasia]
K --> L
Gliadin peptides that cross the now-permeable epithelium are preferentially deamidated by tissue transglutaminase 2 (tTG2), converting glutamine residues to negatively charged glutamic acid → these modified peptides have 100-1000× higher binding affinity for HLA-DQ2 (95% of coeliacs) or HLA-DQ8 (5% of coeliacs) molecules on antigen-presenting cells → presentation to CD4+ T cells in gut-associated lymphoid tissue → clonal expansion of gliadin-specific T cells → release of IFN-γ, TNF-α, IL-15, IL-21 → activation of intraepithelial lymphocytes (IELs) expressing NK receptors → IEL-mediated cytotoxicity against enterocytes → villous atrophy, crypt hyperplasia, malabsorption.
Non-Coeliac Gluten Sensitivity (NCGS) Mechanism:
May involve activation of innate immunity via TLR2 and TLR4 by amylase-trypsin inhibitors (ATIs) present in wheat, barley, and rye → activation of myeloid differentiation primary response 88 (MyD88) → NF-κB translocation → IL-8, TNF-α, IL-1β production → systemic inflammation and extraintestinal symptoms without villous atrophy. FODMAPs co-present in gluten-containing grains may contribute via luminal water retention and fermentation.
Barrier Disruption in All Individuals:
Zonulin-mediated tight junction opening occurs even in healthy non-coeliac individuals, with peak plasma zonulin levels 30-90 minutes post-gluten ingestion. This transient increase in intestinal permeability allows translocation of bacterial LPS (normal gut LPS: <5 pg/mL plasma; post-meal can reach 15-50 pg/mL), food antigens, and incompletely digested proteins. In the context of existing gut dysbiosis, chronic low-grade inflammation, or immune dysregulation, repeated gluten exposure perpetuates the cycle of barrier dysfunction → antigen exposure → immune activation.
Autoimmune Disease Connection:
The zonulin-gluten mechanism provides a molecular explanation for the "leaky gut – autoimmunity" hypothesis. Increased intestinal permeability is documented in type 1 diabetes, Hashimoto's thyroiditis, rheumatoid arthritis, and multiple sclerosis patients before disease onset. The molecular mimicry between deamidated gliadin and self-antigens (e.g., transglutaminase enzymes in multiple tissues) may trigger or perpetuate autoimmune cascades via epitope spreading. Population studies show 20-30× higher coeliac disease prevalence in type 1 diabetes patients; shared HLA-DQ2/DQ8 haplotypes underlie this association.
Neurological Manifestations:
Gliadin-induced zonulin also increases blood-brain barrier permeability by opening tight junctions between endothelial cells. Circulating anti-gliadin antibodies cross-react with Purkinje cells (cerebellar ataxia), synapsin (epilepsy), and GAD65 (stiff-person syndrome variant). "Gluten ataxia" presents with cerebellar signs, positive anti-gliadin antibodies, and cerebellar hypoperfusion on SPECT imaging, often reversible with strict gluten-free diet. Brain fog, anxiety, and depression in NCGS correlate with elevated IL-6, TNF-α, and reduced tryptophan availability for serotonin synthesis.
Intervention Framework (cPNI Perspective):
- Metamodel 0 (Evolutionary mismatch): Modern wheat contains 42 chromosomes vs. ancestral einkorn's 14; gluten content increased 10-50× through selective breeding for baking properties. Human digestive enzymes never evolved to fully process these novel protein structures.
- Metamodel 1 (Remove stressor): Strict gluten-free diet for 3-6 months to allow mucosal healing. Note: "gluten-free" products often contain <20 ppm gluten; even this triggers symptoms in 20-30% of coeliacs.
- Metamodel 2 (Support systems): Betaine HCl + digestive enzymes (especially DPP IV analogs) to enhance proteolytic breakdown; zinc carnosine and L-glutamine to support enterocyte tight junction repair; probiotics (L. rhamnosus GG, L. plantarum) to modulate zonulin expression.
- Clinical threshold: Serum zonulin >50 ng/mL suggests active intestinal permeability; tissue transglutaminase IgA >20 U/mL highly specific for coeliac disease (98% specificity).
- Gluten proteins are 80-85% protein by dry weight; wheat flour is 10-15% gluten
- The 33-mer α2-gliadin peptide (LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF) is the most immunogenic fragment, resistant to all human digestive enzymes
- Zonulin levels rise within 30 minutes of gluten ingestion, peak at 60-90 minutes, return to baseline by 3-4 hours
- HLA-DQ2 (present in 30% of general population) and HLA-DQ8 (10% of population) are necessary but not sufficient for coeliac disease; 3% of carriers develop the disease
- Coeliac disease prevalence: 1% globally, but 70% remain undiagnosed; diagnosis requires positive tTG antibodies + duodenal biopsy showing villous atrophy
- Non-coeliac gluten sensitivity affects an estimated 6-10% of the population; no validated biomarkers exist
- Wheat amylase-trypsin inhibitors (ATIs) comprise 2-4% of wheat protein but trigger TLR4-mediated innate immune activation independent of adaptive gliadin response
- Cross-contamination threshold: <10 mg gluten/day (approx. 1/48th of a slice of bread) can maintain villous atrophy in coeliacs
- Gluten-free diet reduces plasma zonulin by 50-70% within 6 months in coeliac patients
- "Gluten challenge" for diagnosis requires 10 g gluten daily (4 slices of bread) for 2-6 weeks to induce antibody positivity
- Gliadin — the immunogenic prolamin fraction of gluten; the 33-mer peptide drives zonulin release and T-cell activation
- Zonulin — pre-haptoglobin-2 protein released by gliadin-CXCR3 binding; directly opens tight junctions via PAR-2 and EGFR signaling
- Intestinal permeability — gluten universally increases gut barrier permeability through zonulin-mediated tight junction disassembly
- Tight junctions — multiprotein complexes (ZO-1, occludin, claudins) regulated by zonulin; phosphorylation causes reversible opening
- CXCR3 receptor — chemokine receptor on enterocyte apical surface that binds gliadin fragments, initiating zonulin release cascade
- Coeliac disease — HLA-DQ2/DQ8-restricted autoimmune enteropathy triggered by gliadin-tTG neoepitopes; requires lifelong gluten avoidance
- Tissue transglutaminase — enzyme that deamidates gliadin glutamine residues, creating epitopes with 100-1000× higher HLA-DQ2/DQ8 binding affinity
- HLA antigens — HLA-DQ2 (DQA105/DQB102) and HLA-DQ8 (DQA103/DQB10302) molecules that present modified gliadin peptides to CD4+ T cells
- Autoimmunity — gluten-induced permeability facilitates antigen trafficking; molecular mimicry between gliadin and self-proteins (tTG, synapsin, GAD65)
- LPS — bacterial endotoxin that crosses the leaky gut barrier during gluten-induced permeability; activates systemic TLR4 signaling
- TLR4 — recognizes translocated LPS and wheat ATIs; drives NF-κB activation and pro-inflammatory cytokine release
- Amylase-Trypsin-Inhibitor (ATI) — wheat proteins (2-4% of total) that activate innate immunity via TLR4, contributing to NCGS symptoms
- IL-15 — cytokine upregulated in coeliac disease; activates intraepithelial lymphocytes and drives enterocyte apoptosis
- Type 1 diabetes — shares HLA-DQ2/DQ8 susceptibility with coeliac disease; gluten-free diet in infancy may reduce diabetes risk in at-risk children
- Hashimoto's thyroiditis — 10-30% of coeliacs have thyroid autoantibodies; gluten removal reduces TPO antibody titers in some patients
- Dysbiosis — altered gut microbiome in coeliacs shows reduced Bifidobacteria, increased E. coli; gluten-free diet partially restores diversity
- Blood-brain barrier — zonulin increases BBB permeability; anti-gliadin antibodies cross-react with neuronal proteins (cerebellar ataxia, epilepsy)
- Brain fog — common in NCGS and coeliac disease; correlates with elevated IL-6, TNF-α, and reduced cerebral blood flow on imaging
- Systemic inflammation — gluten-induced permeability allows LPS translocation; chronic low-grade inflammation measured by hsCRP elevation
- FODMAPs — fermentable carbohydrates co-present in wheat; contribute to NCGS symptoms via osmotic effects and gas production independent of gluten
- Betaine HCl — supplemental HCl enhances pepsin activity, improving proteolytic breakdown of gliadin in stomach; reduces intact peptide load reaching intestine
- DPP IV — dipeptidyl peptidase IV in brush border; supplemental microbial DPP IV analogs may cleave proline-rich gliadin fragments
- Leaky gut — gluten is the most well-characterized dietary trigger of increased intestinal permeability via the zonulin pathway
- Module 4 — Gluten as a 33-amino-acid food antigen that increases intestinal permeability
- Module 5 — Gliadin issues and the zonulin-mediated tight junction disruption mechanism